8th Translational Research Conference: Myelodysplastic Syndromes

8th Translational Research Conference:
Myelodysplastic Syndromes
April 7-10, 2022 – E-Conference

#ESHMDS2022

Chairs: Pierre Fenaux, Uwe Platzbecker, Mikkael Sekeres

In view of continuing COVID-19 related challenges and uncertainties,
the ESH 8th Translational Research Conference: Myelodysplastic Syndromes
will be held as a VIRTUAL EVENT.

The safety of our speakers and attendees comes first.
We successfully transformed our last 14 conferences into E-Conferences
and will place you in the best dispositions to enjoy the presentations and discussions.

Participants will be joining us from all over the world and from different time zones.
To make sure that everyone has access to the full scientific programme
at a convenient hour, registration will allow participants to join both
the LIVE PROGRAMME: April 7-10, 2022
and the PROGRAMME ON-DEMAND: March 29 – May 10, 2022

REGISTRATION IS OFFERED FREE OF CHARGE
as a gesture of solidarity during these difficult times.

About the E-Conference:

The 8th ESH TRANSLATIONAL RESEARCH CONFERENCE ON MYELODYSPLASTIC SYNDROMES proposes a programme of leading-edge basic and clinical science, as well as opportunities for informal scientific interaction with a panel of global experts in the field.
It is open to an international audience of biologists and clinicians, including those still in-training. This translational research E-Conference will bring together biologists and clinicians with an interest in Myelodysplastic Syndromes (MDS) in order to explore the most recent advances in the understanding of the pathogenesis and clinical behavior of the disease.

New data will be presented and spirited debates on how to best to apply these insights to the future of MDS therapy are expected. Diagnostic, prognostic and therapeutic issues will be presented by the faculty and ample time will be devoted to discussion with delegates.

SCIENTIFIC TOPICS:
• Disease Biology: The Genomics and its consequences in MDS
• Disease Biology: Immune and microenvironment alterations and its implications in MDS
• The future of MDS research
• When is MDS Really MDS, and When is it Really Bad MDS? Diagnosis and Prognosis
• Special Groups in MDS
• Treatment of MDS
• Current Progress in the Treatment of MDS
• Clinical trials in Europe and USA MDS consortium
• Late-Breaking Top News

LEARNING OBJECTIVES:
Upon completion of this CME activity, participants should be able to:
• Learn how to optimally diagnose MDS, mainly by morphological analysis and cytogenetics, but also through the use of new tools, mainly molecular analysis.
• Improve ability to analyze prognostic factors, including new ones (revised IPSS, molecular analysis).
• Review current treatment of MDS, in both the high risk and low risk settings, ranging from single follow up to allogeneic stem cell transplantation.
• Acquire improved knowledge of emerging treatments, based on targeted therapies and well conducted clinical trials.

THE PROGRAMME WILL INCLUDE:
• Plenary Sessions
• Simultaneous Meet the Experts Sessions
• Poster Walks
• Brief Oral Communications
• Keynote lecture
• Controversial Debates
• Ample time for in-depth discussion

This meeting will be of interest to:
• Senior biologists and clinicians, including experts in the field (MD, PhD, MD-PhD)
• Junior biologists and clinicians (MD, PhD)
• Clinical residents still in-training
• Allied health care professionals
 

SUBMISSION OF ABSTRACTS IS NOW CLOSED.

Abstracts guidelines:

– Your abstract has to be structured (eg Objectives, Methods, Results, Conclusions)

– Maximum number of words: 500

– Your abstract will be submitted to the peer review procedure.

The following file types may be uploaded: HTML document (*.htm), HTML document (*.html), JPEG image (*.jpg), GIF image (*.gif), or PNG image (*.png).

N/A

Virtual tour of the E-Conference platform:

With the support of*:

Diamond E-Conference Partner
*******

Emerald E-Conference Partner
*******

Ruby E-Conference Partners
*******

*ESH conference programmes are developed in strict scientific independence
with no input from corporate sponsors.

The registration for the ESH 8th Translational Research Conference: Myelodysplastic Syndromes is offered FREE OF CHARGE, as a gesture of solidarity during these difficult times.

Meet the Expert sessions: Registration fee: 20€
These sessions will be open to E-Conference academic biologists and clinicians registrants only. A maximum of 30 seats will be available in each session and pre-registration will therefore be required.